Galectin Therapeutics Inc.
(NASDAQ : GALT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.03%358.421.2%$822.65m
AMGNAmgen Inc.
-0.43%191.971.2%$549.69m
CELGCelgene Corporation
-0.13%85.671.2%$541.62m
GILDGilead Sciences, Inc.
0.68%77.650.9%$486.04m
SRPTSarepta Therapeutics, Inc.
-0.62%134.5116.6%$345.10m
VRTXVertex Pharmaceuticals Incorporated
-0.23%180.721.9%$321.35m
REGNRegeneron Pharmaceuticals, Inc.
0.12%366.422.6%$293.85m
ILMNIllumina, Inc.
0.82%309.803.5%$269.42m
BLUEBluebird Bio, Inc.
0.06%179.6515.7%$208.27m
NKTRNektar Therapeutics
1.82%48.755.6%$178.62m
ALXNAlexion Pharmaceuticals, Inc.
-0.37%135.152.0%$175.76m
FMIFoundation Medicine, Inc.
0.09%136.938.8%$160.93m
EXASExact Sciences Corporation
0.81%67.2825.4%$160.59m
EXELExelixis, Inc.
0.05%21.346.4%$135.83m
AAgilent Technologies, Inc.
2.03%64.271.5%$132.91m

Company Profile

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs targets the development of carbohdrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.